Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: A promising class of potential antidiabetic agents

Accounts of Chemical Research

Volumn 47, Issue 1, 2014, Pages 211-225

  Mohan, Sankar ^a   Eskandari, Razieh ^a   Pinto, B Mario ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL PRODUCT; ENZYME INHIBITOR; GLUCOSIDASE; SULFUR DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOLOGICAL PRODUCTS; ENZYME INHIBITORS; GLUCOSIDASES; HUMANS; HYPOGLYCEMIC AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFUR COMPOUNDS;

EID: 84892687860     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar400132g     Document Type: Article

References (53)

1. Holman, R. R.; Cull, C. A.; Turner, R. C. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44) Diabetes Care 1999, 22, 960-964
2. Krentz, A. J.; Bailey, C. J. Oral antidiabetic agents-Current role in type 2 diabetes mellitus Drugs 2005, 65, 385-411
3. Mooradian, A. D.; Thurman, J. E. Drug therapy of postprandial hyperglycaemia Drugs 1999, 57, 19-29
4. Vanbeers, E. H.; Buller, H. A.; Grand, R. J.; Einerhand, A. W. C.; Dekker, J. Intestinal brush-border glycohydrolases-Structure, function and development Crit. Rev. Biochem. Mol. Biol. 1995, 30, 197-262
5. Abdullah, M.; Whelan, W. J.; Catley, B. J. Action pattern of human salivary alpha- amylases in vicinity of branch points of amylopectin Carbohydr. Res. 1977, 57, 281-289
6. Brayer, G. D.; Sidhu, G.; Maurus, R.; Rydberg, E. H.; Braun, C.; Wang, Y. L.; Nguyen, N. T.; Overall, C. H.; Withers, S. G. Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques Biochemistry 2000, 39, 4778-4791
7. Sim, L.; Quezada-Calvillo, R.; Sterchi, E. E.; Nichols, B. L.; Rose, D. R. Human intestinal maltase-glucoamylase: Crystal structure of the N -terminal catalytic subunit and basis of inhibition and substrate specificity J. Mol. Biol. 2008, 375, 782-792
8. Dahlqvist, A.; Telenius, U. Column chromatography of human small-intestinal maltase isomaltase and invertase activities Biochem. J. 1969, 111, 139-146
9. Eggermon, E. Hydrolysis of the naturally-occurring alpha-glucosides by the human intestinal mucosa Eur. J. Biochem. 1969, 9, 483-487
10. Quezada-Calvillo, R.; Sim, L.; Ao, Z. H.; Hamaker, B. R.; Quaroni, A.; Brayer, G. D.; Sterchi, E. E.; Robayo-Torres, C. C.; Rose, D. R.; Nichols, B. L. Luminal starch substrate "Brake" on maltase-glucoamylase activity is located within the glucoamylase subunit. Journal of Nutrition J. Nutr. 2008, 138, 685-692
11. Schmidt, D. D.; Frommer, W.; Junge, B.; Muller, L.; Wingender, W.; Truscheit, E.; Schafer, D. Alpha-glucosidase inhibitors-new complex oligosaccharides of microbial origin Naturwissenschaften 1977, 64, 535-536
12. Katsilambros, N.; Philippides, P.; Toskas, A.; Protopapas, J.; Frangaki, D.; Marangos, M.; Siskoudis, P.; Anastasopoulou, K.; Xetteri, H.; Hillebrand, I. A double-blind-study on the efficacy and tolerance of a new alpha-glucosidase inhibitor in type-2 diabetics Arzneimittelforschung 1986, 36-2, 1136-1138
13. Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. Synthesis and alpha-D-glucosidase inhibitory activity of N -substituted valiolamine derivatives as potential oral antidiabetic agents J. Med. Chem. 1986, 29, 1038-1046
14. Godbout, A.; Chiasson, J.-L. Who should benefit from the use of alpha-glucosidase inhibitors? Curr. Diabetes Rep. 2007, 7, 333-339
15. Matsuda, H.; Murakami, T.; Yashiro, K.; Yamahara, J.; Yoshikawa, M. Antidiabetic principles of natural medicines. IV. Aldose reductase and alpha-glucosidase inhibitors from the roots of Salacia oblonga WALL-(Celastraceae): Structure of a new friedelane-type triterpene, kotalagenin 16-acetate Chem. Pharm. Bull. 1999, 47, 1725-1729
16. Vaidyartanam, P. S. Indian Medicinal Plants: a compendium of 500 species; Orient Longman: Madras, India, 1993.
17. Chandrasena, J. P. C. The Chemistry and Pharmacology of Ceylon and Indian Medicinal Plants; H&C Press: Colombo, Sri Lanka, 1935.
18. Jayaweera, D. M. A. Medicinal Plants Used in Ceylon-Part 1; National Science Council of Sri Lanka: Colombo, 1981.
19. Yoshikawa, M.; Murakami, T.; Shimada, H.; Matsuda, H.; Yamahara, J.; Tanabe, G.; Muraoka, O. Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India Tetrahedron Lett. 1997, 38, 8367-8370
20. Yoshikawa, M.; Murakami, T.; Yashiro, K.; Matsuda, H. Kotalanol, a potent alpha- glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata Chem. Pharm. Bull. 1998, 46, 1339-1340
21. Johnston, B. D.; Jensen, H. H.; Pinto, B. M. Synthesis of sulfonium sulfate analogues of disaccharides and their conversion to chain-extended homologues of salacinol: New glycosidase inhibitors J. Org. Chem. 2006, 71, 1111-1118
22. Yoshikawa, M.; Xu, F. M.; Nakamura, S.; Wang, T.; Matsuda, H.; Tanabe, G.; Muraoka, O. Salaprinol and ponkoranol with thiosugar sulfonium sulfate structure from Salacia prinoides and alpha-glucosidase inhibitory activity of ponkoranol and kotalanol desulfate Heterocycles 2008, 75, 1397-1405
23. Minami, Y.; Kurlyarna, C.; Ikeda, K.; Kato, A.; Takebayashi, K.; Adachi, I.; Fleet, G. W. J.; Kettawan, A.; Karnoto, T.; Asano, N. Effect of five-membered sugar mimics on mammalian glycogen-degrading enzymes and various glucosidases Bioorg. Med. Chem. 2008, 16, 2734-2740
24. Tanabe, G.; Xie, W. J.; Ogawa, A.; Cao, C. N.; Minematsu, T.; Yoshikawa, M.; Muraoka, O. Facile synthesis of de- O -sulfated salacinols: Revision of the structure of neosalacinol, a potent alpha-glucosidase inhibitor Bioorg. Med. Chem. Lett. 2009, 19, 2195-2198
25. Jayakanthan, K.; Mohan, S.; Pinto, B. M. Structure proof and synthesis of kotalanol and de- O -sulfonated kotalanol, glycosidase inhibitors isolated from an herbal remedy for the treatment of type-2 diabetes J. Am. Chem. Soc. 2009, 131, 5621-5626
26. Ozaki, S.; Oe, H.; Kitamura, S. Alpha-glucosidase inhibitor from Kothala-himbutu (Salacia reticulata WIGHT) J. Nat. Prod. 2008, 71, 981-984
27. Muraoka, O.; Xie, W. J.; Tanabe, G.; Amer, M. F. A.; Minematsu, T.; Yoshikawa, M. On the structure of the bioactive constituent from ayurvedic medicine Salacia reticulata: revision of the literature Tetrahedron Lett. 2008, 49, 7315-7317
28. Eskandari, R.; Kuntz, D. A.; Rose, D. R.; Pinto, B. M. Potent glucosidase inhibitors: De- O -sulfonated ponkoranol and its stereoisomer Org. Lett. 2010, 12, 1632-1635
29. Xie, W. J.; Tanabe, G.; Akaki, J.; Morikawa, T.; Ninomiya, K.; Minematsu, T.; Yoshikawa, M.; Wu, X. M.; Muraoka, O. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent alpha- glucosidase inhibitors Bioorg. Med. Chem. 2011, 19, 2015-2022
30. Mohan, S.; Pinto, B. M. Zwitterionic glycosidase inhibitors: salacinol and related analogues Carbohydr. Res. 2007, 342, 1551-1580
31. Mohan, S.; Pinto, B. M. Towards the elusive structure of kotalanol, a naturally occurring glucosidase inhibitor Nat. Prod. Rep. 2010, 27, 481-488
32. Mohan, S.; Pinto, B. M. Sulfonium-ion glycosidase inhibitors isolated from Salacia species used in traditional medicine, and related compouds Collect. Czech. Chem. Commun. 2009, 74, 1117-1136
33. Xie, W.; Tanabe, G.; Xu, J.; Wu, X.; Morikawa, T.; Yoshikawa, M.; Muraoka, O. Research progress of synthesis and structure-activity relationship studies on sulfonium-type -glucosidase inhibitors isolated from salacia genus plants Mini-Rev. Org. Chem. 2013, 10, 141-159
34. Muraoka, O.; Xie, W. J.; Osaki, S.; Kagawa, A.; Tanabe, G.; Amer, M. F. A.; Minematsu, T.; Morikawa, T.; Yoshikawa, M. Characteristic alkaline catalyzed degradation of kotalanol, a potent alpha-glucosidase inhibitor isolated from ayurvedic traditional medicine Salacia reticulata, leading to anhydroheptitols: another structural proof Tetrahedron 2010, 66, 3717-3722
35. Eskandari, R.; Jayakanthan, K.; Kuntz, D. A.; Rose, D. R.; Pinto, B. M. Synthesis of a biologically active isomer of kotalanol, a naturally occurring glucosidase inhibitor Bioorg. Med. Chem. 2010, 18, 2829-2835
36. Sim, L.; Jayakanthan, K.; Mohan, S.; Nasi, R.; Johnston, B. D.; Pinto, B. M.; Rose, D. R. New glucosidase inhibitors from an ayurvedic herbal treatment for type 2 diabetes: Structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata Biochemistry 2010, 49, 443-451
37. Nasi, R.; Patrick, B. O.; Sim, L.; Rose, D. R.; Pinto, B. M. Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: Synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol J. Org. Chem. 2008, 73, 6172-6181
38. Mohan, S.; Jayakanthan, K.; Nasi, R.; Kuntz, D. A.; Rose, D. R.; Pinto, B. M. Synthesis and biological evaluation of heteroanalogues of kotalanol and de- O -sulfonated kotalanol Org. Lett. 2010, 12, 1088-1091
39. Mohan, S.; Sim, L.; Rose, D. R.; Pinto, B. M. Probing the active-site requirements of human intestinal N-terminal maltase-glucoamylase: Synthesis and enzyme inhibitory activities of a six-membered ring nitrogen analogue of kotalanol and its de- O -sulfonated derivative Bioorg. Med. Chem. 2010, 18, 7794-7798
40. Xie, W.; Tanabe, G.; Matsuoka, K.; Amer, M. F. A.; Minematsu, T.; Wu, X.; Yoshikawa, M.; Muraoka, O. Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor Bioorg. Med. Chem. 2011, 19, 2252-2262
41. Tanabe, G.; Matsuoka, K.; Yoshinaga, M.; Xie, W.; Tsutsui, N.; A. Amer, M. F.; Nakamura, S.; Nakanishi, I.; Wu, X.; Yoshikawa, M.; Muraoka, O. Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor. Part 2 Bioorg. Med. Chem. 2012, 20, 6321-6334
42. Eskandari, R.; Jones, K.; Rose, D. R.; Pinto, B. M. The effect of heteroatom substitution of sulfur for selenium in glucosidase inhibitors on intestinal alpha-glucosidase activities Chem. Commun. 2011, 47, 9134-9136
43. Jones, K.; Sim, L.; Mohan, S.; Kumarasamy, J.; Liu, H.; Avery, S.; Naim, H. Y.; Quezada-Calvillo, R.; Nichols, B. L.; Pinto, B. M.; Rose, D. R. Mapping the intestinal alpha-glucogenic enzyme specificities of starch digesting maltase-glucoamylase and sucrase-isomaltase Bioorg. Med. Chem. 2011, 19, 3929-3934
44. Sim, L.; Willemsma, C.; Mohan, S.; Naim, H. Y.; Pinto, B. M.; Rose, D. R. Structural basis for substrate selectivity in human maltase-glucoamylase and sucrase-isomaltase N-terminal domains J. Biol. Chem. 2010, 285, 17763-17770
45. Naumoff, D. G. Structure and evolution of the mammalian maltase-glucoamylase and sucrase-isomaltase genes Mol. Biol. 2007, 41, 962-973
46. Eskandari, R.; Jones, K.; Rose, D. R.; Pinto, B. M. Probing the active-site requirements of human intestinal N-terminal maltase glucoamylase: The effect of replacing the sulfate moiety by a methyl ether in ponkoranol, a naturally occurring alpha-glucosidase inhibitor Bioorg. Med. Chem. Lett. 2010, 20, 5686-5689
47. Eskandari, R.; Jones, K.; Rose, D. R.; Pinto, B. M. Selectivity of 3′- O -methylponkoranol for inhibition of N- and C-terminal maltase glucoamylase and sucrase isomaltase, potential therapeutics for digestive disorders or their sequelae Bioorg. Med. Chem. Lett. 2011, 21, 6491-6494
48. Tanabe, G.; Otani, T.; Cong, W. Y.; Minematsu, T.; Ninomiya, K.; Yoshikawa, M.; Muraoka, O. Biological evaluation of 3′- O -alkylated analogs of salacinol, the role of hydrophobic alkyl group at 3′ position in the side chain on the alpha-glucosidase inhibitory activity Bioorg. Med. Chem. Lett. 2011, 21, 3159-3162
49. Tanabe, G.; Nakamura, S.; Tsutsui, N.; Balakishan, G.; Xie, W.; Tsuchiya, S.; Akaki, J.; Morikawa, T.; Ninomiya, K.; Nakanishi, I.; Yoshikawa, M.; Muraoka, O. In silico design, synthesis and evaluation of 3′- O -benzylated analogs of salacinol, a potent alpha- glucosidase inhibitor isolated from an ayurvedic traditional medicine " Salacia " Chem. Commun. 2012, 48, 8646-8648
50. Ren, L.; Qin, X.; Cao, X.; Wang, L.; Bai, F.; Bai, G.; Shen, Y. Structural insight into substrate specificity of human intestinal maltase-glucoamylase Protein Cell 2011, 2, 827-836
51. Eskandari, R.; Jones, K.; Reddy, K. R.; Jayakanthan, K.; Chaudet, M.; Rose, D. R.; Pinto, B. M. Probing the intestinal alpha-glucosidase enzyme specificities of starch-digesting maltase-glucoamylase and sucrase-isomaltase: Synthesis and inhibitory properties of 3′- and 5′-maltose-extended de- O -sulfonated ponkoranol Chem. Eur. J. 2011, 17, 14817-14825
52. Lee, B. H.; Eskandari, R.; Jones, K.; Reddy, K. R.; Quezada-Calvillo, R.; Nichols, B. L.; Rose, D. R.; Hamaker, B. R.; Pinto, B. M. Modulation of starch digestion for slow glucose release through "toggling" of activities of mucosal alpha-glucosidases J. Biol. Chem. 2012, 287, 31929-31938
53. Zhang, G. Y.; Hamaker, B. R. Slowly digestible starch: Concept, mechanism, and proposed extended glycemic index Crit. Rev. Food Sci. Nutr. 2009, 49, 852-867